167 related articles for article (PubMed ID: 11380029)
21. Influence of Morphometry on Echocardiographic Measurements in Cavalier King Charles Spaniels: An Inverse Probability Weighting Analysis.
Bagardi M; Ghilardi S; Locatelli C; Bionda A; Polli M; Bussadori CM; Colombo FM; Pazzagli L; Brambilla PG
Vet Sci; 2021 Sep; 8(10):. PubMed ID: 34679035
[TBL] [Abstract][Full Text] [Related]
22. Chronic mitral valve disease in cavalier King Charles spaniels: 95 cases (1987-1991).
Beardow AW; Buchanan JW
J Am Vet Med Assoc; 1993 Oct; 203(7):1023-9. PubMed ID: 8135932
[TBL] [Abstract][Full Text] [Related]
23. Heart rate, heart rate variability, and arrhythmias in dogs with myxomatous mitral valve disease.
Rasmussen CE; Falk T; Zois NE; Moesgaard SG; Häggström J; Pedersen HD; Ablad B; Nilsen HY; Olsen LH
J Vet Intern Med; 2012; 26(1):76-84. PubMed ID: 22151356
[TBL] [Abstract][Full Text] [Related]
24. Serum serotonin concentration is associated with severity of myxomatous mitral valve disease in dogs.
Ljungvall I; Höglund K; Lilliehöök I; Oyama MA; Tidholm A; Tvedten H; Häggström J
J Vet Intern Med; 2013; 27(5):1105-12. PubMed ID: 23865457
[TBL] [Abstract][Full Text] [Related]
25. Echocardiographic mitral valve prolapse in cavalier King Charles spaniels: epidemiology and prognostic significance for regurgitation.
Pedersen HD; Lorentzen KA; Kristensen BO
Vet Rec; 1999 Mar; 144(12):315-20. PubMed ID: 10212505
[TBL] [Abstract][Full Text] [Related]
26. Validation of Advia plateletcrit for assessing platelet mass in dogs, including Cavalier King Charles spaniels.
Tvedten HW; Lilliehöök IE; Oberg J; Häggström J; Höglund K; Ljungvall I
Vet Clin Pathol; 2012 Sep; 41(3):336-43. PubMed ID: 22954296
[TBL] [Abstract][Full Text] [Related]
27. Relationship between syringomyelia and myxomatous mitral valve disease in Cavalier King Charles spaniels.
Bach MBT; Stougaard CL; Thøfner MS; Reimann MJ; Westrup U; Koch J; Fredholm M; Martinussen T; Berendt M; Olsen LH
J Vet Intern Med; 2024; 38(2):904-912. PubMed ID: 38391152
[TBL] [Abstract][Full Text] [Related]
28. Comparison of methods for determining platelet numbers and volume in Cavalier King Charles spaniels.
Bertazzolo W; Comazzi S; Sesso L; Scarpa P; Ru G; Paltrinieri S
J Small Anim Pract; 2007 Oct; 48(10):556-61. PubMed ID: 17543023
[TBL] [Abstract][Full Text] [Related]
29. No impact of polymorphism in the phosphodiesterase 5A gene in Cavalier King Charles Spaniels on pimobendan-induced inhibition of platelet aggregation response.
Reimann MJ; Faisst DN; Knold M; Meurs KM; Stern JA; Cremer SE; Møller JE; Ljungvall I; Häggström J; Olsen LH
J Vet Intern Med; 2023; 37(6):2145-2156. PubMed ID: 37743723
[TBL] [Abstract][Full Text] [Related]
30. Use of physical examination, electrocardiography, radiography, and biomarkers to predict echocardiographic stage B2 myxomatous mitral valve disease in preclinical Cavalier King Charles Spaniels.
Wesselowski S; Gordon SG; Fries R; Saunders AB; Sykes KT; Vitt J; Boutet B; Häggström J; Kadotani S; Stack J; Barnett BG
J Vet Cardiol; 2023 Dec; 50():1-16. PubMed ID: 37913604
[TBL] [Abstract][Full Text] [Related]
31. Increased NT-proANP predicts risk of congestive heart failure in Cavalier King Charles spaniels with mitral regurgitation caused by myxomatous valve disease.
Eriksson AS; Häggström J; Pedersen HD; Hansson K; Järvinen AK; Haukka J; Kvart C
J Vet Cardiol; 2014 Sep; 16(3):141-54. PubMed ID: 25130405
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of genes associated with human myxomatous mitral valve disease in dogs with familial myxomatous mitral valve degeneration.
Meurs KM; Friedenberg SG; Williams B; Keene BW; Atkins CE; Adin D; Aona B; DeFrancesco T; Tou S; Mackay T
Vet J; 2018 Feb; 232():16-19. PubMed ID: 29428085
[TBL] [Abstract][Full Text] [Related]
33. Idiopathic asymptomatic thrombocytopenia in Cavalier King Charles Spaniels is an autosomal recessive trait.
Pedersen HD; Häggstrom J; Olsen LH; Christensen K; Selin A; Burmeister ML; Larsen H
J Vet Intern Med; 2002; 16(2):169-73. PubMed ID: 11899033
[TBL] [Abstract][Full Text] [Related]
34. Macrothrombocytosis in cavalier King Charles spaniels.
Brown SJ; Simpson KW; Baker S; Spagnoletti MA; Elwood CM
Vet Rec; 1994 Sep; 135(12):281-3. PubMed ID: 7817507
[TBL] [Abstract][Full Text] [Related]
35. Giant platelet disorder in the Cavalier King Charles Spaniel.
Cowan SM; Bartges JW; Gompf RE; Hayes JR; Moyers TD; Snider CC; Gerard DA; Craft RM; Muenchen RA; Carroll RC
Exp Hematol; 2004 Apr; 32(4):344-50. PubMed ID: 15050744
[TBL] [Abstract][Full Text] [Related]
36. Determinants of weak femoral artery pulse in dogs with mitral valve prolapse.
Tarnow I; Olsen LH; Jensen MB; Pedersen KM; Pedersen HD
Res Vet Sci; 2004 Apr; 76(2):113-20. PubMed ID: 14672853
[TBL] [Abstract][Full Text] [Related]
37. Body size, but neither age nor asymptomatic mitral regurgitation, influences plasma concentrations of dimethylarginines in dogs.
Pedersen LG; Tarnow I; Olsen LH; Teerlink T; Pedersen HD
Res Vet Sci; 2006 Jun; 80(3):336-42. PubMed ID: 16182327
[TBL] [Abstract][Full Text] [Related]
38. Polymorphisms in the serotonin transporter gene and circulating concentrations of neurotransmitters in Cavalier King Charles Spaniels with myxomatous mitral valve disease.
Reimann MJ; Fredholm M; Cremer SE; Christiansen LB; Meurs KM; Møller JE; Häggström J; Lykkesfeldt J; Olsen LH
J Vet Intern Med; 2021 Nov; 35(6):2596-2606. PubMed ID: 34599615
[TBL] [Abstract][Full Text] [Related]
39. Echocardiographic measurement of the mitral valve in normal Cavalier King Charles spaniels: repeatability, optimal future study methods, and preliminary reference intervals.
Wesselowski S; Saunders AB; Werre S; Gordon SG
J Vet Cardiol; 2022 Oct; 43():81-92. PubMed ID: 36099705
[TBL] [Abstract][Full Text] [Related]
40. Mutation in beta1-tubulin correlates with macrothrombocytopenia in Cavalier King Charles Spaniels.
Davis B; Toivio-Kinnucan M; Schuller S; Boudreaux MK
J Vet Intern Med; 2008; 22(3):540-5. PubMed ID: 18466252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
